BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 9255155)

  • 1. Localization of iodine-125-mIP-Des-Met14-bombesin (7-13)NH2 in ovarian carcinoma induced to express the gastrin releasing peptide receptor by adenoviral vector-mediated gene transfer.
    Rogers BE; Rosenfeld ME; Khazaeli MB; Mikheeva G; Stackhouse MA; Liu T; Curiel DT; Buchsbaum DJ
    J Nucl Med; 1997 Aug; 38(8):1221-9. PubMed ID: 9255155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor localization of a radiolabeled bombesin analogue in mice bearing human ovarian tumors induced to express the gastrin-releasing peptide receptor by an adenoviral vector.
    Rogers BE; Curiel DT; Mayo MS; Laffoon KK; Bright SJ; Buchsbaum DJ
    Cancer; 1997 Dec; 80(12 Suppl):2419-24. PubMed ID: 9406692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral-mediated delivery of gastrin-releasing peptide receptor results in specific tumor localization of a bombesin analogue in vivo.
    Rosenfeld ME; Rogers BE; Khazaeli MB; Mikheeva G; Raben D; Mayo MS; Curiel DT; Buchsbaum DJ
    Clin Cancer Res; 1997 Jul; 3(7):1187-94. PubMed ID: 9815798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo localization of [(111)In]-DTPA-D-Phe1-octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vector.
    Rogers BE; McLean SF; Kirkman RL; Della Manna D; Bright SJ; Olsen CC; Myracle AD; Mayo MS; Curiel DT; Buchsbaum DJ
    Clin Cancer Res; 1999 Feb; 5(2):383-93. PubMed ID: 10037188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific membrane receptor gene expression targeted with radiolabeled peptide employing the erbB-2 and DF3 promoter elements in adenoviral vectors.
    Stackhouse MA; Buchsbaum DJ; Kancharla SR; Grizzle WE; Grimes C; Laffoon K; Pederson LC; Curiel DT
    Cancer Gene Ther; 1999; 6(3):209-19. PubMed ID: 10359206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.
    Zhang X; Cai W; Cao F; Schreibmann E; Wu Y; Wu JC; Xing L; Chen X
    J Nucl Med; 2006 Mar; 47(3):492-501. PubMed ID: 16513619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells.
    Reile H; Armatis PE; Schally AV
    Prostate; 1994 Jul; 25(1):29-38. PubMed ID: 8022709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer.
    Lantry LE; Cappelletti E; Maddalena ME; Fox JS; Feng W; Chen J; Thomas R; Eaton SM; Bogdan NJ; Arunachalam T; Reubi JC; Raju N; Metcalfe EC; Lattuada L; Linder KE; Swenson RE; Tweedle MF; Nunn AD
    J Nucl Med; 2006 Jul; 47(7):1144-52. PubMed ID: 16818949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of a new bombesin analog for imaging of gastrin-releasing peptide receptors.
    Shirmardi SP; Gandomkar M; Maragheh MG; Shamsaei M
    Cancer Biother Radiopharm; 2011 Jun; 26(3):309-16. PubMed ID: 21711115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
    Chen X; Park R; Hou Y; Tohme M; Shahinian AH; Bading JR; Conti PS
    J Nucl Med; 2004 Aug; 45(8):1390-7. PubMed ID: 15299066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical pharmacokinetic, biodistribution, imaging and therapeutic efficacy of (177)Lu-Labeled glycated bombesin analogue for gastrin-releasing peptide receptor-positive prostate tumor targeting.
    Lim JC; Cho EH; Kim JJ; Choi SM; Lee SY; Nam SS; Park UJ; Park SH
    Nucl Med Biol; 2015 Mar; 42(3):234-41. PubMed ID: 25498002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14).
    Biddlecombe GB; Rogers BE; de Visser M; Parry JJ; de Jong M; Erion JL; Lewis JS
    Bioconjug Chem; 2007; 18(3):724-30. PubMed ID: 17378600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of 64Cu-labeled SarAr-bombesin analogs in gastrin-releasing peptide receptor-expressing prostate cancer.
    Lears KA; Ferdani R; Liang K; Zheleznyak A; Andrews R; Sherman CD; Achilefu S; Anderson CJ; Rogers BE
    J Nucl Med; 2011 Mar; 52(3):470-7. PubMed ID: 21321264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.
    Haubner R; Wester HJ; Burkhart F; Senekowitsch-Schmidtke R; Weber W; Goodman SL; Kessler H; Schwaiger M
    J Nucl Med; 2001 Feb; 42(2):326-36. PubMed ID: 11216533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel glycated [99mTc(CO)3]-labeled bombesin analogues for improved targeting of gastrin-releasing peptide receptor-positive tumors.
    Schweinsberg C; Maes V; Brans L; Bläuenstein P; Tourwé DA; Schubiger PA; Schibli R; García Garayoa E
    Bioconjug Chem; 2008 Dec; 19(12):2432-9. PubMed ID: 19053304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
    Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
    Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue.
    Rogers BE; Bigott HM; McCarthy DW; Della Manna D; Kim J; Sharp TL; Welch MJ
    Bioconjug Chem; 2003; 14(4):756-63. PubMed ID: 12862428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99mTc radiotracers based on human GRP(18-27): synthesis and comparative evaluation.
    Marsouvanidis PJ; Maina T; Sallegger W; Krenning EP; de Jong M; Nock BA
    J Nucl Med; 2013 Oct; 54(10):1797-803. PubMed ID: 24009275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evaluation of a 64Cu-labeled polyethylene glycol-bombesin conjugate.
    Rogers BE; Manna DD; Safavy A
    Cancer Biother Radiopharm; 2004 Feb; 19(1):25-34. PubMed ID: 15068608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.